Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer
Condition: Breast Cancer Interventions: Drug: Ribociclib; Radiation: Postoperative Radiation Therapy Sponsor: University of Michigan Rogel Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials